SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-224532
Filing Date
2019-08-19
Accepted
2019-08-19 16:47:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A d769559ds3a.htm S-3/A 37727
2 EX-23.1 d769559dex231.htm EX-23.1 1673
  Complete submission text file 0001193125-19-224532.txt   40485
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-228206 | Film No.: 191036965
SIC: 2834 Pharmaceutical Preparations